IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

ZECCHINI, SILVIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.385
AS - Asia 2.870
EU - Europa 2.752
SA - Sud America 252
AF - Africa 53
OC - Oceania 30
Totale 9.342
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.238
IT - Italia 1.158
CN - Cina 865
SG - Singapore 778
GB - Regno Unito 400
DE - Germania 340
HK - Hong Kong 291
BD - Bangladesh 241
BR - Brasile 194
IN - India 175
VN - Vietnam 160
RU - Federazione Russa 145
SE - Svezia 135
FR - Francia 127
NL - Olanda 105
CA - Canada 100
KR - Corea 74
DK - Danimarca 67
FI - Finlandia 64
IE - Irlanda 58
ID - Indonesia 55
TR - Turchia 49
JP - Giappone 43
AU - Australia 28
MX - Messico 26
BE - Belgio 23
AR - Argentina 21
PL - Polonia 20
AT - Austria 19
UA - Ucraina 18
CZ - Repubblica Ceca 16
CH - Svizzera 14
IR - Iran 13
MO - Macao, regione amministrativa speciale della Cina 13
PH - Filippine 13
CI - Costa d'Avorio 12
EC - Ecuador 12
TW - Taiwan 11
ES - Italia 10
TH - Thailandia 10
IQ - Iraq 9
UZ - Uzbekistan 9
ZA - Sudafrica 8
EG - Egitto 7
IL - Israele 7
MY - Malesia 7
CL - Cile 6
GT - Guatemala 6
LT - Lituania 6
PK - Pakistan 6
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
CO - Colombia 5
RO - Romania 5
SC - Seychelles 5
CR - Costa Rica 4
EU - Europa 4
JO - Giordania 4
KE - Kenya 4
KG - Kirghizistan 4
MA - Marocco 4
NP - Nepal 4
TN - Tunisia 4
AL - Albania 3
AZ - Azerbaigian 3
BO - Bolivia 3
CY - Cipro 3
GR - Grecia 3
HU - Ungheria 3
KZ - Kazakistan 3
NG - Nigeria 3
NI - Nicaragua 3
PE - Perù 3
RS - Serbia 3
UY - Uruguay 3
VE - Venezuela 3
DO - Repubblica Dominicana 2
DZ - Algeria 2
EE - Estonia 2
ET - Etiopia 2
JM - Giamaica 2
LA - Repubblica Popolare Democratica del Laos 2
LU - Lussemburgo 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
GA - Gabon 1
GE - Georgia 1
HN - Honduras 1
HR - Croazia 1
KH - Cambogia 1
LB - Libano 1
LV - Lettonia 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
PY - Paraguay 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
Totale 9.342
Salva come PNG Salva come JPEG
Città #
Milan 475
Singapore 449
Ashburn 400
Southend 331
Hong Kong 260
Fairfield 222
San Jose 210
Dallas 177
Santa Clara 149
Chandler 141
Frankfurt am Main 134
Beijing 127
Council Bluffs 111
Seattle 105
Los Angeles 100
Hefei 99
Houston 98
Wilmington 90
Woodbridge 90
New York 84
Boardman 69
Cambridge 69
Rome 67
Hanover 65
Ann Arbor 60
Dublin 57
Ho Chi Minh City 49
Dearborn 48
Jakarta 48
Princeton 45
Bengaluru 44
Buffalo 44
Hanoi 41
Phoenix 41
Seoul 41
Guangzhou 39
Munich 37
Lauterbourg 36
Helsinki 35
Tokyo 33
Bodio Lomnago 29
Moscow 28
Istanbul 26
Naples 26
Shanghai 26
Toronto 26
Nuremberg 25
Atlanta 23
Nanjing 23
The Dalles 23
Brussels 20
Berlin 19
Des Moines 19
Bari 18
Cangzhou 18
Columbus 18
Edmonton 17
London 17
Fuzhou 16
Orem 16
São Paulo 16
Bologna 15
Chicago 15
Dong Ket 15
Warsaw 15
Brno 14
Jinan 14
Turin 14
Bergamo 13
Busto Arsizio 13
Macao 13
Abidjan 12
Hyderabad 12
Melbourne 12
Redwood City 12
Chennai 11
Redmond 11
Shenyang 11
Toulouse 11
Washington 11
Zhengzhou 11
Changsha 10
Hangzhou 10
Lappeenranta 10
Mexico City 10
Montreal 10
Monza 10
Piscataway 10
Xian 10
Da Nang 9
Hebei 9
Manila 9
Mumbai 9
San Francisco 9
Stockholm 9
Tianjin 9
Turku 9
Vienna 9
Amsterdam 8
Nanchang 8
Totale 5.701
Salva come PNG Salva come JPEG
Nome #
SRT2104, a new SIRT1 activator, is an effective metabolic enhancer that promotes muscle recovery in DMD 507
Defects of full-length dystrophin trigger retinal neuron damage and synapse alterations by disrupting functional autophagy 409
Acid Sphingomyelinase Downregulation Enhances Mitochondrial Fusion and Promotes Oxidative Metabolism in a Mouse Model of Melanoma 361
Autophagy controls neonatal myogenesis by regulating the GH-IGF1 system through a NFE2L2- and DDIT3-mediated mechanism 357
Drp1 overexpression induces desmin disassembling and drives kinesin-1 activation promoting mitochondrial trafficking in skeletal muscle 338
Givinostat as metabolic enhancer reverting mitochondrial biogenesis deficit in Duchenne Muscular Dystrophy 334
Nitric Oxide Generated by Tumor-Associated Macrophages Is Responsible for Cancer Resistance to Cisplatin and Correlated With Syntaxin 4 and Acid Sphingomyelinase Inhibition 326
Essential role for acid sphingomyelinase-inhibited autophagy in melanoma response to cisplatin 314
Acid sphingomyelinase controls early phases of skeletal muscle regeneration by shaping the macrophage phenotype 307
Epigenetic modifications of the PGC-1α promoter in Limb Girdle Muscular Dystrophy 2D account for impaired mitochondrial biogenesis : new perspective in HDAC inhibitors as therapeutic strategy of muscular dystrophy I. 296
The natural compound climacostol as a prodrug strategy based on pH activation for efficient delivery of cytotoxic small agents 296
Characterisation of Progressive Skeletal Muscle Fibrosis in the Mdx Mouse Model of Duchenne Muscular Dystrophy: An In Vivo and In Vitro Study 279
XIAP as a Target of New Small Organic Natural Molecules Inducing Human Cancer Cell Death 263
Reversal of Defective Mitochondrial Biogenesis in Limb-Girdle Muscular Dystrophy 2D by Independent Modulation of Histone and PGC-1α Acetylation 262
Dysfunctional autophagy induced by the pro-apoptotic natural compound climacostol in tumour cells 258
A complex remodeling of cellular homeostasis distinguishes RSV/SARS-CoV-2 co-infected A549-hACE2 expressing cell lines 256
The Numb/p53 circuitry couples replicative self-renewal and tumor suppression in mammary epithelial cells 251
Pre-clinical validation of a selective anti-cancer stem cell therapy for Numb-deficient human breast cancers 245
The adhesion molecule NCAM promotes ovarian cancer progression via FGFR signalling 240
RACK1 is evolutionary conserved in satellite stem cell activation and adult skeletal muscle regeneration 232
Oxidative Stress and Autophagy as Key Targets in Melanoma Cell Fate 224
Dopamine Reduces SARS-CoV-2 Replication In Vitro through Downregulation of D2 Receptors and Upregulation of Type-I Interferons 221
Climacostol reduces tumour progression in a mouse model of melanoma via the p53-dependent intrinsic apoptotic programme 215
Alpha-synuclein dynamics bridge Type-I Interferon response and SARS-CoV-2 replication in peripheral cells 210
SARS-CoV-2 hampers dopamine production in iPSC-derived dopaminergic neurons 205
SRT2104, a new SIRT1 activator, is an effective metabolic enhancer that promotes muscle recovery in DMD 196
The simultaneous downregulation of TRPM7 and MagT1 in human mesenchymal stem cells in vitro: Effects on growth and osteogenic differentiation 194
SRT2104, a new specific SIRT1 activator, promotes muscle recovery enhancing mitochondrial metabolism in DMD 165
Cryopreserved placental biopsies maintain mitochondrial activity for high-resolution respirometry 164
Targeting mitochondrial dynamics to tackle duchenne muscular dystrophy progression 160
Targeting mitochondrial dynamics to tackle Duchenne Muscular Dystrophy progression 158
Neuroprotective role of plumbagin on eye damage induced by high-sucrose diet in adult fruit fly Drosophila melanogaster 153
SRT2104, a new SIRT1 activator, is an effective metabolic enhancer that promotes muscle recovery in DMD 149
The differential role of L1 in ovarian carcinoma and normal ovarian surface epithelium 144
Impact of Drp1 activation and fission induction in the pathogenesis of DMD progression 142
Targeting mitochondrial dynamics to tackle Duchenne muscular dystrophy progression 132
Hypogonadotropic hypogonadism and peripheral neuropathy in Ebf2-null mice 121
Characterization of collagen content and turnover in skeletal muscles in a mouse model of Duchenne muscular dystrophy: in vivo and in vitro analysis 115
Enhancing micro-dystrophin gene therapy: the role of SRT2104, a new Sirtuin1-activating compound, for the treatment of Duchenne Muscular Dystrophy 97
Natural products from aquatic eukaryotic microorganisms for cancer therapy: perspectives on anti-tumour properties of ciliate bioactive molecules 93
Targeting mitochondrial dynamics to tackle Duchenne muscular dystrophy progression 91
Enhancing micro-dystrophin gene therapy: the role of SRT2104, a new Sirtuin1-activating compound, for the treatment of Duchenne Muscular Dystrophy 85
Enhancing micro-dystrophin gene therapy: the role of SRT2104, a new Sirtuin1-activating compound, for the treatment of Duchenne Muscular Dystrophy 72
SRT2104 improves muscle and cognitive outcomes and has the potential to enhance µDys gene therapy in DMD 2
SRT2104 improves muscle and cognitive outcomes and has the potential to enhance µDys gene therapy in DMD 1
Totale 9.640
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.516
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.516
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022659 44 47 32 41 42 29 66 44 84 83 46 101
2022/2023610 79 58 58 43 51 112 26 34 64 21 54 10
2023/2024681 12 15 47 55 122 38 35 47 38 64 92 116
2024/20251.826 75 161 63 160 164 106 131 182 122 171 168 323
2025/20263.782 338 320 449 297 280 183 386 147 353 258 335 436
2026/2027125 125 0 0 0 0 0 0 0 0 0 0 0
Totale 9.640